Search Results - Kijlstra, Jelle

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Abstract CT205: Phase 2 study to evaluate the safety, pharmacokinetics, and clinical activity of the PI3K / mTOR inhibitor paxalisib (GDC-0084) in glioblastoma (GBM) with unmethylated O6-methylguanine-methyltransferase (MGMT) promotor status

    Abstract CT205: Phase 2 study to evaluate the safety, pharmacokinetics, and clinical activity of the PI3K / mTOR inhibitor paxalisib (GDC-0084) in glioblastoma (GBM) with unmethyla... by Wen, Patrick Y., de Groot, John, Battiste, James D., Goldlust, Samuel A., Garner, James S., Simpson, Jeremy A., Kijlstra, Jelle, Olivero, Alan, Cloughesy, Timothy

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    ACTR-64. PHASE 2 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS AND CLINICAL ACTIVITY OF PI3K/mTOR INHIBITOR GDC-0084 IN GBM PATIENTS WITH UNMETHYLATED O6-METHYLGUANINE-METHYLTRANSFERASE (MGMT) PROMOTER STATUS

    ACTR-64. PHASE 2 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS AND CLINICAL ACTIVITY OF PI3K/mTOR INHIBITOR GDC-0084 IN GBM PATIENTS WITH UNMETHYLATED O6-METHYLGUANINE-METHYLTRANS... by Wen, Patrick, DeGroot, John, Battiste, James, Goldlust, Samuel, Garner, James, Simpson, Jeremy, Kijlstra, Jelle, Olivero, Alan, Cloughesy, Timothy

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: